Hypertension, HIV infection, and highly active antiretrovíric therapy;Hipertensión arterial, infección por el virus de la inmunodeficiencia humana y tratamiento antirretrovírico de gran actividad

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 28, Issue 1, 2010, Pages 32-37

  Bernardino de la Serna, José Ignacio ^a   Xavier Zamora, Francisco ^a   Luisa Montes, María ^a   García Puig, Juan ^a   Ramón Arribas, José ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Arterial hypertension; HAART; HIV infection

Indexed keywords

ANTIRETROVIRUS AGENT; ATAZANAVIR; EFAVIRENZ; INDINAVIR; LOPINAVIR; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; RITONAVIR; SAQUINAVIR;

BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; GLOMERULONEPHRITIS; HEART INFARCTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; INTERSTITIAL NEPHRITIS; MORTALITY; NEPHROLITHIASIS; PREVALENCE; SHORT SURVEY; SYSTOLIC BLOOD PRESSURE;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ATHEROSCLEROSIS; BLOOD PRESSURE; COHORT STUDIES; DYSLIPIDEMIAS; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; HYPERTENSION; INSULIN RESISTANCE; KIDNEY DISEASES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MODELS, BIOLOGICAL; MULTICENTER STUDIES AS TOPIC; MYOCARDIAL ISCHEMIA; PREVALENCE;

EID: 73249144869     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2008.07.005     Document Type: Short Survey

References (41)

1. Palella Jr. F.J., Delaney K.M., Moorman A.C., Loveless M.O., Fuhrer J., Satten G.A., et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338 (1998) 853-860
2. Henry K., Melroe H., Huebsch J., Hermundson J., Levine C., Swensen L., et al. Severe premature coronary artery disease with protease inhibitors. Lancet 351 (1998) 1328
3. Bozzette S.A., Ake C.F., Tam H.K., Chang S.W., and Louis T.A. Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection. N Engl J Med 348 (2003) 702-710
4. Friis-Moller N., Sabin C.A., Weber R., D'Arminio Monforte A., El-Sadr W.M., Reiss P., et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 349 (2003) 1993-2003
5. Friis-Moller N., Reiss P., Sabin C.A., Weber R., Monforte A., El-Sadr W., et al. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med 356 (2007) 1723-1735
6. Holmberg S.D., Moorman A.C., Williamson J.M., Tong T.C., Ward D.J., Wood K.C., et al. Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet 360 (2002) 1747-1748
7. Triant V.A., Lee H., Hadigan C., and Grinspoon S.K. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab 92 (2007) 2506-2512
8. Saves M., Chene G., Ducimetiere P., Leport C., Le Moal G., Amouyel P., et al. Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population. Clin Infect Dis 37 (2003) 292-298
9. Carr A., Samaras K., Thorisdottir A., Kaufmann G.R., Chisholm D.J., and Cooper D.A. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: A cohort study. Lancet 353 (1999) 2093-2099
10. Pickering T.G., Shimbo D., and Haas D. Ambulatory blood-pressure monitoring. N Engl J Med 354 (2006) 2368-2374
11. Aoun S., and Ramos E. Hypertension in the HIV-infected patient. Curr Hypertens Rep 2 (2000) 478-481
12. Cattelan A.M., Trevenzoli M., Sasset L., Rinaldi L., Balasso V., and Cadrobbi P. Indinavir and systemic hypertension. Aids 15 (2001) 805-807
13. Mattana J., Siegal F.P., Sankaran R.T., and Singhal P.C. Absence of age-related increase in systolic blood pressure in ambulatory patients with HIV infection. Am J Med Sci 317 (1999) 232-237
14. Seaberg E.C., Munoz A., Lu M., Detels R., Margolick J.B., Riddler S.A., et al. Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS 19 (2005) 953-960
15. Friis-Moller N., Weber R., Reiss P., Thiebaut R., Kirk O., D'Arminio Monforte A., et al. Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study. AIDS 17 (2003) 1179-1193
16. Bergersen B.M., Sandvik L., Dunlop O., Birkeland K., and Bruun J.N. Prevalence of hypertension in HIV-positive patients on highly active antiretroviral therapy (HAART) compared with HAART-naive and HIV-negative controls: Results from a Norwegian study of 721 patients. Eur J Clin Microbiol Infect Dis 22 (2003) 731-736
17. Klein D., Hurley L.B., Quesenberry Jr. C.P., and Sidney S. Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?. J Acquir Immune Defic Syndr 30 (2002) 471-477
18. Palacios R., Santos J., García A., Castells E., González M., Ruíz J., et al. Impact of highly active antiretroviral therapy on blood pressure in HIV-infected patients. A prospective study in a cohort of naive patients. HIV Med 7 (2006) 10-15
19. Gazzaruso C., Bruno R., Garzaniti A., Giordanetti S., Fratino P., Sacchi P., et al. Hypertension among HIV patients: Prevalence and relationships to insulin resistance and metabolic syndrome. J Hypertens 21 (2003) 1377-1382
20. Jerico C., Knobel H., Montero M., Sorli M.L., Guelar A., Gimeno J.L., et al. Hypertension in HIV-infected patients: Prevalence and related factors. Am J Hypertens 18 (2005) 1396-1401
21. Sattler F.R., Qian D., Louie S., Johnson D., Briggs W., De Quattro V., et al. Elevated blood pressure in subjects with lipodystrophy. AIDS 15 (2001) 2001-2010
22. Hadigan C., Meigs J.B., Corcoran C., Rietschel P., Piecuch S., Basgoz N., et al. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis 32 (2001) 130-139
23. Thiebaut R., El-Sadr W.M., Friis-Moller N., Rickenbach M., Reiss P., Monforte A.D., et al. Predictors of hypertension and changes of blood pressure in HIV-infected patients. Antivir Ther 10 (2005) 811-823
24. Beunza J.J., Martínez-González M.A., Serrano-Martínez M., and Alonso A. Incidencia de hipertensión arterial en una cohorte de graduados universitarios españoles: el estudio SUN. Rev Esp Cardiol 59 (2006) 1331-1334
25. Gutiérrez Fuentes J.A., Gómez-Jerique J., Gómez de la Cámara A., Ángel Rubio M., García Hernández A., and Aristegui I. Dieta y riesgo cardiovascular en España (DRECE II). Descripción de la evolución del perfil cardiovascular. Med Clin (Barc) 115 (2000) 726-729
26. Cameron D.W., Japour A.J., Xu Y., Hsu A., Mellors J., Farthing C., et al. Ritonavir and saquinavir combination therapy for the treatment of HIV infection. AIDS 13 (1999) 213-224
27. th Conference on Retrovirus and Oportunistic Infections; February 25-28, 2007; Los Angeles, California. p. Abstract 38.
28. Hewitt RG, Thompson IV WM, Chu A, Hernandez F, Shelton MJ. Indinavir, not nelfinavir, is associated with systemic hypertension when compared to no protease inhibitor therapy. Abstracts of the International AIDS Conference. Chicago; 2001. Poster 658.
29. Crane H.M., Van Rompaey S.E., and Kitahata M.M. Antiretroviral medications associated with elevated blood pressure among patients receiving highly active antiretroviral therapy. AIDS 20 (2006) 1019-1026
30. Martínez E., López Bernaldo de Quirós J.C., Miralles C., and Podzamczer D. Considerations on the increase in blood pressure among antiretroviral-naive patients starting HAART. AIDS 21 (2007) 384-386
31. Selik R.M., Byers Jr. R.H., and Dworkin M.S. Trends in diseases reported on US death certificates that mentioned HIV infection, 1987-1999. J Acquir Immune Defic Syndr 29 (2002) 378-387
32. Gupta S.K., Eustace J.A., Winston J.A., Boydstun I.I., Ahuja T.S., Rodríguez R.A., et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 40 (2005) 1559-1585
33. Han T.M., Naicker S., Ramdial P.K., and Assounga A.G. A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa. Kidney Int 69 (2006) 2243-2250
34. Wyatt C.M., Arons R.R., Klotman P.E., and Klotman M.E. Acute renal failure in hospitalized patients with HIV: Risk factors and impact on in-hospital mortality. AIDS 20 (2006) 561-565
35. Crowther M.A., Callaghan W., Hodsman A.B., and Mackie I.D. Dideoxyinosine-associated nephrotoxicity. AIDS 7 (1993) 131-132
36. Szczech L.A., Gupta S.K., Habash R., Guasch A., Kalayjian R., Appel R., et al. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int 66 (2004) 1145-1152
37. Jung O., Bickel M., Ditting T., Rickerts V., Welk T., Helm E.B., et al. Hypertension in HIV-1-infected patients and its impact on renal and cardiovascular integrity. Nephrol Dial Transplant 19 (2004) 2250-2258
38. O'Brien E., Asmar R., Beilin L., Imai Y., Mallion J.M., Mancia G., et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 21 (2003) 821-848
39. Saves M., Raffi F., Capeau J., Rozenbaum W., Ragnaud J.M., Perronne C., et al. Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy. Clin Infect Dis 34 (2002) 1396-1405
40. Martinez E, Arribas JR, Lopez-Aldeguer J, Gutierrez F, Miralles C, Lozano F, et al. Factors associated with a high cardiovascular risk in HIV-infected patients in Spain: A multicenter, nation-wide, cross-sectional study. Abstracts of the International AIDS Conference. Boston; 2005. Poster 870.
41. Jericó C., Knobel H., Sorli M.L., Montero M., Guelar A., and Pedro-Botet J. Prevalencia de factores de riesgo cardiovascular en pacientes con infección por el VIH. Rev Clin Esp 206 (2006) 556-559